Are NOACs always the best strategy in elderly AF patients?-Reference-Cited by-同舟云学术

Are NOACs always the best strategy in elderly AF patients?

Published:2023-11-29 Issue: Volume: Page:
ISSN:2055-6837
Container-title:European Heart Journal - Cardiovascular Pharmacotherapy
language:en
Short-container-title:

Author:

Iguchi Moritake¹^ORCID,Tamargo Juan²,Hasegawa Koji³^ORCID

Affiliation:

1. Department of Cardiac Rehabilitation, National Hospital Organization Kyoto Medical Center , 612-8555 Kyoto , Japan

2. Department of Pharmacology and Toxicology, School of Medicine, Universidad Complutense, Instituto de Investigación Sanitaria Gregorio Marañón , 28040 Madrid , Spain

3. Division of Translational Research, National Hospital Organization Kyoto Medical Center , 612-8555 Kyoto , Japan

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine

Link

https://academic.oup.com/ehjcvp/advance-article-pdf/doi/10.1093/ehjcvp/pvad094/54329668/pvad094.pdf

Reference7 articles.

1. Oral anticoagulation in very elderly patients with atrial fibrillation;Chao;Circulation,2018

2. Use of oral anticoagulant therapy in older adults with atrial fibrillation after acute ischemic stroke;Mcgrath;J Am Geriatr Soc,2017

3. Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex;Carnicelli;Circulation,2022

4. Net clinical benefit of non-vitamin K antagonist vs. vitamin K antagonist anticoagulants in elderly patients with atrial fibrillation;Patti;Am J Med,2019

5. Safety of switching from a vitamin K antagonist to a non-vitamin K antagonist oral anticoagulant in frail older patients with atrial fibrillation: results of the FRAIL-AF randomized controlled Trial;Joosten,2023